
198.56 Delayed Data As of Jan 19 | ![]() Today’s Change | 117.06 Today|||52-Week Range 199.52 | +17.60% Year-to-Date |
The 16 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 195.00, with a high estimate of 227.00 and a low estimate of 150.00. The median estimate represents a -1.79% decrease from the last price of 198.56.
The current consensus among 19 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.